Sonja Kappel

Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development

Sanda Šturlan, Georg Oberhuber, Britta G. Beinhauer et al. · Carcinogenesis · 2001 · 98 citations · Full text

Medicine, Genetics, Oncology +17

TP53 Genotype but Not p53 Immunohistochemical Result Predicts Response to Preoperative Short-Term Radiotherapy in Rectal Cancer

Daniela Kandioler, Ronald Zwrtek, Carmen Ludwig et al. · Annals of Surgery · 2002 · 90 citations

Medicine, Oncology, Pathology +17

Contralateral Breast Cancer: Molecular Differentiation Between Metastasis and Second Primary Cancer

Elisabeth Janschek, Daniela Kandioler-Eckersberger, Carmen Ludwig et al. · Breast Cancer Research and Treatment · 2001 · 71 citations

Medicine, Oncology, Surgery +16

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients

Daniela Kandioler, Martina Mittlböck, Sonja Kappel et al. · EBioMedicine · 2015 · 55 citations · Full text

Medicine, Molecular Genetics, Oncology +16

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study

Daniela Kandioler, Sebastian F. Schoppmann, Ronald Zwrtek et al. · Journal of Thoracic and Cardiovascular Surgery · 2014 · 51 citations · Full text

Medicine, Molecular Genetics, Oncology +14